The PE Ratio as of November 2024 (TTM) for REGENXBIO Inc. (RGNX) is -1.68

According to REGENXBIO Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.68. This represents a change of -46.63% compared to the average of -3.15 of the last 4 quarters.

REGENXBIO Inc. (RGNX) Historical PE Ratio (quarterly & annually)

How has RGNX PE Ratio performed in the past?

The mean historical PE Ratio of REGENXBIO Inc. over the last ten years is -13.94. The current -1.68 PE Ratio has changed 1.11% with respect to the historical average. Over the past ten years (40 quarters), RGNX's PE Ratio was at its highest in in the December 2018 quarter at 87.56. The PE Ratio was at its lowest in in the June 2019 quarter at -320.13.

REGENXBIO Inc. (RGNX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of REGENXBIO Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

REGENXBIO Inc. (RGNX) Average PE Ratio

How has RGNX PE Ratio performed in the past?

The current PE Ratio of REGENXBIO Inc. (RGNX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

REGENXBIO Inc. (RGNX) PE Ratio vs. Peers

How is RGNX’s PE Ratio compared to its peers?

REGENXBIO Inc.’s PE Ratio is greater than Day One Biopharmaceuticals, Inc. (-16.94), greater than Replimune Group, Inc. (-3.74), greater than Mirum Pharmaceuticals, Inc. (-17.89), greater than Rocket Pharmaceuticals, Inc. (-6.29), greater than Avidity Biosciences, Inc. (-17.73), less than uniQure N.V. (-1.00), less than Protagonist Therapeutics, Inc. (16.87), greater than Pliant Therapeutics, Inc. (-4.73), greater than Immunocore Holdings plc (-26.36), greater than Revolution Medicines, Inc. (-17.52), greater than Monte Rosa Therapeutics, Inc. (-4.86), greater than Stoke Therapeutics, Inc. (-6.92), less than AN2 Therapeutics, Inc. (-0.50), less than Passage Bio, Inc. (-0.51), greater than 4D Molecular Therapeutics, Inc. (-4.07), greater than Crinetics Pharmaceuticals, Inc. (-17.32), less than LianBio (-0.49), greater than Kezar Life Sciences, Inc. (-5.33),

Build a custom stock screener for REGENXBIO Inc. (RGNX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like REGENXBIO Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

REGENXBIO Inc. (RGNX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like REGENXBIO Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.